These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32205471)

  • 1. The retina revolution: signaling pathway therapies, genetic therapies, mitochondrial therapies, artificial intelligence.
    Wood EH; Korot E; Storey PP; Muscat S; Williams GA; Drenser KA
    Curr Opin Ophthalmol; 2020 May; 31(3):207-214. PubMed ID: 32205471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STEM CELL THERAPIES, GENE-BASED THERAPIES, OPTOGENETICS, AND RETINAL PROSTHETICS: Current State and Implications for the Future.
    Wood EH; Tang PH; De la Huerta I; Korot E; Muscat S; Palanker DA; Williams GA
    Retina; 2019 May; 39(5):820-835. PubMed ID: 30664120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver nano - a trove for retinal therapies.
    Kalishwaralal K; Barathmanikanth S; Pandian SR; Deepak V; Gurunathan S
    J Control Release; 2010 Jul; 145(2):76-90. PubMed ID: 20359511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal anti-angiogenesis by a new route.
    Bicknell R
    Nat Biotechnol; 2008 May; 26(5):528-9. PubMed ID: 18464784
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of artificial intelligence on retinal disease management: Vision Academy retinal expert consensus.
    Danese C; Kale AU; Aslam T; Lanzetta P; Barratt J; Chou YB; Eldem B; Eter N; Gale R; Korobelnik JF; Kozak I; Li X; Li X; Loewenstein A; Ruamviboonsuk P; Sakamoto T; Ting DSW; van Wijngaarden P; Waldstein SM; Wong D; Wu L; Zapata MA; Zarranz-Ventura J
    Curr Opin Ophthalmol; 2023 Sep; 34(5):396-402. PubMed ID: 37326216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retinal angiomatous proliferations].
    Heußen FM; Ouyang Y; Joussen AM
    Klin Monbl Augenheilkd; 2012 Sep; 229(9):877-81. PubMed ID: 22903355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low risk to retina from sustained suppression of VEGF.
    Campochiaro PA
    J Clin Invest; 2019 Jun; 129(8):3029-3031. PubMed ID: 31232701
    [No Abstract]   [Full Text] [Related]  

  • 8. Artificial vision: principles and prospects.
    Gilhooley MJ; Acheson J
    Curr Opin Neurol; 2017 Feb; 30(1):55-60. PubMed ID: 27984304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for genetic and acquired retinal diseases.
    Chaum E; Hatton MP
    Surv Ophthalmol; 2002; 47(5):449-69. PubMed ID: 12431694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in pediatric retina.
    Cai S; Therattil A; Vajzovic L
    Curr Opin Ophthalmol; 2020 May; 31(3):155-160. PubMed ID: 32168002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatments and preventive strategies for radiation retinopathy.
    Reichstein D
    Curr Opin Ophthalmol; 2015 May; 26(3):157-66. PubMed ID: 25730680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis.
    Nakahara T; Morita A; Yagasaki R; Mori A; Sakamoto K
    Biol Pharm Bull; 2017; 40(12):2045-2049. PubMed ID: 29199229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Presentation of Chorioretinal Folds-Related Maculopathy.
    Corvi F; Capuano V; Benatti L; Bandello F; Souied E; Querques G
    Optom Vis Sci; 2016 Oct; 93(10):1304-14. PubMed ID: 27560847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway.
    Itatani Y; Kawada K; Yamamoto T; Sakai Y
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The revolution in the treatment of retinal diseases: anti-VEGF treatment at the Assuta Eye Institute].
    Katz G; Zehavi C; Treister G
    Harefuah; 2015 Apr; 154(4):270-3, 278. PubMed ID: 26065226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New frontiers of retinal therapeutic intervention: a critical analysis of novel approaches.
    Nanegrungsunk O; Au A; Sarraf D; Sadda SR
    Ann Med; 2022 Dec; 54(1):1067-1080. PubMed ID: 35467460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of retinal gene therapy.
    Lipinski DM; Thake M; MacLaren RE
    Prog Retin Eye Res; 2013 Jan; 32():22-47. PubMed ID: 22995954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system.
    Tie J; Desai J
    Crit Rev Oncog; 2012; 17(1):51-67. PubMed ID: 22471664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current practice in the management of branch retinal vein occlusion in Japan: Survey results of retina specialists in Japan.
    Ogura Y; Kondo M; Kadonosono K; Shimura M; Kamei M; Tsujikawa A
    Jpn J Ophthalmol; 2019 Sep; 63(5):365-373. PubMed ID: 31428900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab compared with photodynamic therapy with verteporfin for group 2a parafoveal retinal telangiectasis.
    Windisch R; Kozousek V
    Can J Ophthalmol; 2008 Aug; 43(4):489-90. PubMed ID: 18711474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.